文献速递胃肠外科围术期管理与 ERAS

围术期生理复杂度轨迹与结直肠癌术后分子残留病及长期结局的关联

Perioperative physiological complexity trajectories and their association with molecular residual disease and long-term outcomes after curative colorectal cancer surgery: a prospective cohort study.
PubMed 文献 · Surg Endosc · 2026-05-22

这项前瞻性队列研究纳入1000例根治性结直肠癌手术患者,基于可穿戴设备构建围术期生理复杂度评分(PCS)并识别出三种恢复轨迹。持续复杂度抑制与主要并发症率更高、ctDNA-MRD持续阳性风险增加及更差的无病生存和总生存相关,PCS为探索性宿主恢复表型。

要点

  • 可穿戴设备衍生的PCS轨迹可分为保留、短暂丢失和持续抑制三型。
  • 持续复杂度抑制与主要并发症率更高及ctDNA-MRD持续阳性风险增加相关。
  • PCS轨迹与DFS和OS相关,但属观察性假设生成,需外部验证。

核心结论

  • 可穿戴设备衍生的PCS轨迹与结直肠癌术后并发症、ctDNA-MRD持续阳性及长期结局相关。
  • PCS为探索性宿主恢复表型,非直接免疫或肿瘤生物学指标,不建立因果关系。

研究设计与样本

  • 前瞻性队列研究,纳入1000例接受根治性结直肠癌手术的患者,随访60个月。
  • 使用术前至术后第30天的连续可穿戴数据构建复合生理复杂度评分(PCS),整合心脏自主神经复杂度、休息-活动转换组织和睡眠-觉醒转换结构。
  • 各组分方向对齐、标准化后按预设等权重合并,未使用结局衍生优化。
  • 通过轨迹建模识别围术期恢复模式,并采用多变量模型、非线性分析、校准评估、决策曲线分析和敏感性分析评估关联。

主要发现

  • 识别出三种PCS轨迹:保留复杂度(n=403)、短暂复杂度丢失(n=372)和持续复杂度抑制(n=225)。
  • 持续复杂度抑制与更高的主要并发症率相关(18.2% vs 10.9%,P=0.006)。
  • 持续复杂度抑制与ctDNA-MRD持续阳性风险增加相关(调整OR 3.02,95%CI 2.10-4.35;P<0.001)。
  • 持续复杂度抑制与更差的无病生存(调整HR 1.89,95%CI 1.45-2.47)和总生存(调整HR 1.76,95%CI 1.29-2.41)相关。
  • 敏感性分析结果方向一致;加入PCS改善了探索性预后校准和净临床获益。

临床怎么用

  • PCS轨迹可作为术后风险分层的探索性工具,辅助识别可能发生并发症及ctDNA-MRD持续阳性的高危患者。
  • 目前PCS尚不能替代ctDNA-MRD或常规临床病理变量,需外部验证和阈值校准后方可临床实施。

局限性

  • 观察性研究,不能确立因果关系。
  • PCS为研究性宿主恢复表型,非直接免疫或肿瘤生物学测量。
  • 临床实施前需外部验证、阈值校准、设备 harmonization 及前瞻性临床效用研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative recovery and long-term outcomes after curative colorectal cancer surgery remain heterogeneous. Although circulating tumor DNA-based minimal residual disease (ctDNA-MRD) provides tumor-specific prognostic information, dynamic host-recovery processes are not captured. We evaluated whether wearable-derived perioperative physiological complexity trajectories, operationalized as a multidomain host-recovery phenotype, provide prognostic information complementary to clinicopathologic variables and ctDNA-MRD. METHODS: In this prospective cohort study, 1000 patients undergoing curative-intent colorectal cancer surgery were followed for 60 months. Continuous wearable-derived data from the preoperative period through postoperative day 30 were used to construct a composite physiological complexity score (PCS). PCS integrated cardiac autonomic complexity, rest-activity transition organization, and sleep-wake transition structure. Components were direction-aligned, standardized, and combined using prespecified equal weighting without outcome-derived optimization. Trajectory modeling identified perioperative recovery patterns. Associations with postoperative complications, ctDNA-MRD persistence, disease-free survival (DFS), and overall survival (OS) were evaluated using multivariable models, nonlinear analyses, calibration assessment, decision curve analysis, and sensitivity analyses. RESULTS: Three PCS trajectories were identified: preserved complexity (n = 403), transient complexity loss (n = 372), and persistent complexity suppression (n = 225). Persistent complexity suppression was associated with higher major complication rates (18.2% vs 10.9%, P = 0.006) and increased ctDNA-MRD persistence (adjusted OR 3.02, 95% CI 2.10-4.35; P < 0.001). Over 60 months, persistent complexity suppression was associated with worse DFS (adjusted HR 1.89, 95% CI 1.45-2.47) and OS (adjusted HR 1.76, 95% CI 1.29-2.41). Findings were directionally consistent across sensitivity analyses. Adding PCS improved exploratory prognostic calibration and net clinical benefit. CONCLUSION: Wearable-derived PCS trajectories were associated with postoperative morbidity, ctDNA-MRD persistence, and long-term outcomes after colorectal cancer surgery. PCS represents an investigational host-recovery phenotype, not a direct immune or tumor-biology measure. These observational findings are hypothesis-generating and do not establish causality. External validation, threshold calibration, device harmonization, and prospective clinical utility studies are required before clinical implementation.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pan S, Wang G. Perioperative physiological complexity trajectories and their association with molecular residual disease and long-term outcomes after curative colorectal cancer surgery: a prospective cohort study. Surg Endosc. 2026. PMID: 42171714. doi:10.1007/s00464-026-12915-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。